propiverine

DRUG5 trials

Sponsors

Pfizer, Takeda, Astellas Pharma Singapore Pte. Ltd., Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital

Conditions

Overactive BladderOveractive Bladder (OAB)Overactive Bladder SyndromeUrinary Bladder, Overactive

Phase 3

A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic Monitoring

CompletedNCT00646880

PfizerUrinary Bladder, Overactive

Start: 2003-03-31End: 2003-08-31Updated: 2008-03-31

Unknown Phase

Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome

CompletedNCT02024945

TakedaOveractive Bladder Syndrome

Start: 2010-11-30End: 2011-12-31Updated: 2013-12-31

A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China

CompletedNCT03572231

Astellas Pharma Singapore Pte. Ltd.Overactive Bladder (OAB)

Start: 2018-07-19End: 2020-03-30Updated: 2020-04-22

Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania

CompletedNCT03602508

Astellas Pharma Singapore Pte. Ltd.Overactive Bladder (OAB)

Start: 2018-07-20End: 2019-09-13Updated: 2024-10-16

Treatment of Overactive Bladder With Anticholinergic Agents

Active, not recruitingNCT07046156

Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research HospitalOveractive Bladder

Start: 2022-09-01End: 2026-06-01Target: 120Updated: 2025-07-01

Related Papers

Response to anticholinergic therapy and its predictors in pediatric overactive bladder.

2025-11-03

Treatment Patterns with Mirabegron and Antimuscarinics for Overactive Bladder: A Prospective, Registry Study in Taiwan and South Korea (FAITH).

2024-03-022 citations

A treatment prediction strategy for overactive bladder using a machine learning algorithm that utilized data from the FAITH study

Neurourology and Urodynamics2023-05-065 citations